Dan Matlow, the CEO of VitalHub.Handout
VitalHub Corp. VHI-T is a small-cap stock that has delivered healthy returns to shareholders.
Last year, shares of this health-care stock jumped 54 per cent. Returns accelerated in 2024 with the share price rallying nearly 48 per cent in the first quarter. The Street believes further gains are in store for investors. The stock has six unanimous buy recommendations and an average target price of $7.54, according to Refinitiv Eikon.
Driving the positive price momentum are strong and improving company fundamentals. In 2023, VitalHub reported record revenue of $52.5 million, up 31 per cent year-over-year. Annual recurring revenue, or ARR, came in at $44.6 million, rising 23 per cent year-over-year, providing a high percentage of predictable revenue. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) increased 40 per cent year-over-year to over…
